Community Health Systems, Inc. (CYH)
Healthcare
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 2
Do Nothing: fundamentalScore 2 and qualitativeScore 2 are both below the required floor of 3 (the shadow flag is rendered false, so the SHADOW_FST9 paper branch is unavailable) and no long entry is admissible; independently, avgDollarVolume20 $4,977,352 is below the $5,000,000 liquidity floor and the max overnight gap of 9.05% (2026-11-03 regular close 2.045 to 2026-11-04 regular open 2.23) exceeds the 5% limit. Neither entry archetype rescues it: a pullback limit is countertrend (price 2.38 below SMA50 2.82 with MACD -0.16 below zero, and below a declining SMA200) and a breakout buy-stop above the nearest settled resistance 2.44 would enter into a falling SMA20/50/200 stack with no trend confirmation.
Company overview
Community Health Systems, Inc. operates as a healthcare provider in the U.S., managing general acute care hospitals. It offers a range of medical services, including emergency care, surgeries, and diagnostic capabilities, alongside psychiatric and rehabilitation services. The company also provides outpatient services through a network of facilities, including primary care and urgent care centers.
Fundamental
weakCommunity Health Systems exhibits high leverage and negative cash flow, with legal risks and a shrinking operational base.
Levered hospital operator whose FY2025 profit was manufactured by divestiture and debt-extinguishment gains while 2026 interim results turned loss-making with negative operating cash flow; negative book equity, ~7.2x net debt to Adjusted EBITDA and ~1.0x interest coverage are offset only by ample ABL liquidity, no near-term maturities and no going-concern or covenant issues. Weak, high-risk fundamentals - below the actionable threshold.
Sentiment
weakSentiment is negative following a Q3 earnings miss and guidance cut, with no positive catalysts in sight.
Dominant driver is the announced Q3 2026 earnings miss and the reset of full-year guidance to a net loss of $217–231M (2026-10-28), which took roughly 16% off the shares and was followed by a Truist price-target cut to $2.50 from $3.25 (2026-11-03) — an entirely bearish actionable catalyst set with no offsetting bullish leg. The media-sentiment delta is determinate-negative (baseline polarity ≈ +0.01 versus scoring polarity ≈ −0.21); the Red-Flag Screen produced no severe flag, but a moderate flag for sharply deteriorating sentiment (≤14d) with no offsetting bullish catalyst fired, so a moderate red-flag cap applied and the score settled on the weak-evidence row rather than the top of the capped range.
Technical
weakThe stock is in a downtrend, with recent price action reflecting an oversold bounce rather than a trend reversal.
Chart quality scores 2: bounce-only. CYH at 2.38 sits below SMA20 (2.71), SMA50 (2.82), SMA200 (3.02), EMA9 (2.45) and EMA21 (2.63) with a falling 20/50/200-day stack, MACD at -0.16/-0.09/-0.07 and ADX 25.4 rising against the price — a strong DOWN trend by construction. The 2026-11-04 session (+16.1% to 2.38 on 4.58M shares, closing one cent off the 2.39 high) is an oversold bounce off RSI 21.3 / Williams %R -99 that reclaimed only WMA9, DEMA14 and TEMA14; it is not a trend reversal. The trade is blocked regardless of chart: fundamentalScore 2 and qualitativeScore 2 are both below the required floor of 3, avgDollarVolume20 $4,977,352 is under the $5,000,000 liquidity floor, and the 2026-11-03 to 2026-11-04 regular-session gap of 9.05% exceeds the 5% overnight-gap limit.
You’re looking at 2026-11-05 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

